Less than half of those who tested positive for HIV in Pretoria were aware of their HIV status. As such they would not have ...

Hepatitis affects millions worldwide, leading to serious liver damage. Expert shares everything you need to know about the ...

Hepatitis C virus (HCV) infection among individuals without a history of injection drug use (IDU) is “sizeable” despite the higher HCV rates among those with a history of IDU, according to study ...

Earlier this month, Kezar Life Sciences announced that the mid-stage test of zetomipzomib in lupus nephritis had been placed ...

Based on research and analysis of the global Pluripotent stem cell drug market, as well as studies and evaluations of relevant companies in the industry, Frost & Sullivan has granted ZEPHYRM ...

Alchemy, which sets up pharmacies in community clinics, said that it had raised $31 million from Andreessen Horowitz and ...

Currently, there are no specific antiviral drugs available for treating hepatitis E virus (HEV) infection, which represents a global health burden, causing acute viral hepatitis with varying clinical ...

The global hepatitis C virus (HCV) testing market is poised for significant growth, with its market size expected to ...

The following is a summary of "Feasibility and Performance of a Point-of-Care Hepatitis C RNA Assay in a Community ...

Oklahoma legalized needle exchange programs three years ago. Since then, over half a million clean syringes have been ...

No. Antiviral treatment is the best approach for hep C. But you can complement your treatment with approaches like diet and ...

The risk for HCV reinfection among patients who reported injection drug use was increased in the initial period after curative treatment but decreased over time.